Literature DB >> 8879212

Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.

M Pasparakis1, L Alexopoulou, V Episkopou, G Kollias.   

Abstract

To investigate the role of TNF alpha in the development of in vivo immune response we have generated TNF alpha-deficient mice by gene targeting. Homozygous mutant mice are viable and fertile, develop lymph nodes and Peyer's patches and show no apparent phenotypic abnormalities, indicating that TNF alpha is not required for normal mouse development. In the absence of TNF alpha mice readily succumb to L. monocytogenes infections and show reduced contact hypersensitivity responses. Furthermore, TNF alpha knockout mice are resistant to the systemic toxicity of LPS upon D-galactosamine sensitization, yet they remain sensitive to high doses of LPS alone. Most interestingly, TNF alpha knockout mice completely lack splenic primary B cell follicles and cannot form organized follicular dendritic cell (FDC) networks and germinal centers. However, despite the absence of B cell follicles, Ig class-switching can still occur, yet deregulated humoral immune responses against either thymus-dependent (TD) or thymus-independent (TI) antigens are observed. Complementation of TNF alpha functioning by the expression of either human or murine TNF alpha transgenes is sufficient to reconstitute these defects, establishing a physiological role for TNF alpha in regulating the development and organization of splenic follicular architecture and in the maturation of the humoral immune response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879212      PMCID: PMC2192824          DOI: 10.1084/jem.184.4.1397

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  53 in total

1.  Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.

Authors:  A Ashkenazi; S A Marsters; D J Capon; S M Chamow; I S Figari; D Pennica; D V Goeddel; M A Palladino; D H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex.

Authors:  K Tomonari
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector.

Authors:  E Robertson; A Bradley; M Kuehn; M Evans
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

4.  Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor.

Authors:  L A Tartaglia; D V Goeddel; C Reynolds; I S Figari; R F Weber; B M Fendly; M A Palladino
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

5.  A lymphotoxin-beta-specific receptor.

Authors:  P D Crowe; T L VanArsdale; B N Walter; C F Ware; C Hession; B Ehrenfels; J L Browning; W S Din; R G Goodwin; C A Smith
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

6.  Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization.

Authors:  M Cumberbatch; I Kimber
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

7.  Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor.

Authors:  E Decoster; B Vanhaesebroeck; P Vandenabeele; J Grooten; W Fiers
Journal:  J Biol Chem       Date:  1995-08-04       Impact factor: 5.157

8.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

9.  Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor.

Authors:  B Neumann; A Luz; K Pfeffer; B Holzmann
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

10.  Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions.

Authors:  P F Piguet; G E Grau; C Hauser; P Vassalli
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  363 in total

Review 1.  Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models.

Authors:  S R Ruuls; J D Sedgwick
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

Review 2.  Local immune responses in afferent and efferent lymph.

Authors:  D M Haig; J Hopkins; H R Miller
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

3.  TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models.

Authors:  G Kassiotis; G Kollias
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  Characterization of tumor necrosis factor-deficient mice.

Authors:  M W Marino; A Dunn; D Grail; M Inglese; Y Noguchi; E Richards; A Jungbluth; H Wada; M Moore; B Williamson; S Basu; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

5.  Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.

Authors:  K B Elkon; C C Liu; J G Gall; J Trevejo; M W Marino; K A Abrahamsen; X Song; J L Zhou; L J Old; R G Crystal; E Falck-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

6.  Perforin plays an unexpected role in regulating T-cell contraction during prolonged Listeria monocytogenes infection.

Authors:  Nathan W Schmidt; Aaruni Khanolkar; Lisa Hancox; Jonathan W Heusel; John T Harty
Journal:  Eur J Immunol       Date:  2012-01-18       Impact factor: 5.532

7.  Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity.

Authors:  Joanne A O'Donnell; Jesse Lehman; Justine E Roderick; Dalia Martinez-Marin; Matija Zelic; Ciara Doran; Nicole Hermance; Stephen Lyle; Manolis Pasparakis; Katherine A Fitzgerald; Ann Marshak-Rothstein; Michelle A Kelliher
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

8.  TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.

Authors:  Ganesan Ramesh; W Brian Reeves
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.

Authors:  A Picchianti Diamanti; M M Rosado; M Scarsella; V Germano; E Giorda; S Cascioli; B Laganà; R D'Amelio; R Carsetti
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

10.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.

Authors:  Thomas Calzascia; Marc Pellegrini; Håkan Hall; Laurent Sabbagh; Nobuyuki Ono; Alisha R Elford; Tak W Mak; Pamela S Ohashi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.